ScholarIQanswers from OpenAlex & ORCID
Iwona Ługowska
ResearcherPublications, citations & collaboration network
Iwona Ługowska is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Iwona Ługowska have?
ScholarIQindexed works
Iwona Ługowska has 249 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Iwona Ługowska have?
ScholarIQcitation count
Iwona Ługowska has 8,114 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Iwona Ługowska?
ScholarIQh-index
Iwona Ługowska has an h-index of 32 in OpenAlex.
What is the i10-index of Iwona Ługowska?
ScholarIQi10-index
Iwona Ługowska has an i10-index of 75 in OpenAlex.
What is the ORCID of Iwona Ługowska?
ScholarIQorcid
The ORCID for Iwona Ługowska is on the source record.
What is the OpenAlex record for Iwona Ługowska?
ScholarIQopenalex
The OpenAlex for Iwona Ługowska is on the source record.
What are the most-cited papers on Iwona Ługowska?
ScholarIQmost cited works
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali, N. Abecassis, Sebastian Bauer, R. Biagini, Stefan Bielack, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Thomas Brodowicz, J.M. Broto, Angela Buonadonna, E. De Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Palma Dileo, Mikael Eriksson, Alexander N. Fedenko, Virginia Ferraresi, Andrea Ferrari, Stefano Ferrari, Anna Maria Frezza, Silvia Gasperoni, Hans Gelderblom, Thierry Gil, Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, Alho Hannu, A. Bassim Hassan, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
Funda Meric‐Bernstam, Vicky Makker, Ana Oaknin, Do‐Youn Oh, Susana Banerjee, Antonio González-Martı́n, Kyung Hae Jung, Iwona Ługowska, Luís Manso, Aránzazu Manzano, Bohuslav Melichar, Salvatore Siena, Daniil Stroyakovskiy, Anitra Fielding, Yan Ma, Soham D. Puvvada, Norah J. Shire, Jung‐Yun Lee
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali, N. Abecassis, Sebastian Bauer, R. Biagini, Stefan Bielack, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Thomas Brodowicz, J.M. Broto, Angela Buonadonna, E. De Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Palma Dileo, Mikael Eriksson, А. А. Феденко, Virginia Ferraresi, Andrea Ferrari, S. Ferrari, Anna Maria Frezza, Silvia Gasperoni, Hans Gelderblom, Thierry Gil, Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, Alho Hannu, A. Bassim Hassan, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali, Stefan Bielack, N. Abecassis, Hannu T. Aro, Sebastian Bauer, R. Biagini, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Bernadette Brennan, Thomas Brodowicz, J.M. Broto, Laurence Brugières, Angela Buonadonna, E. De Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Palma Dileo, Catharina Dhooge, Mikael Eriksson, Franca Fagioli, Alexander N. Fedenko, Virginia Ferraresi, Andrea Ferrari, Stefano Ferrari, Anna Maria Frezza, Nathalie Gaspar, Silvia Gasperoni, Hans Gelderblom, Thierry Gil, Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, A. Bassim Hassan, Stefanie Hecker‐Nolting, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Leo Kager, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Ruth Ladenstein, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Bruce Morland, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Sandra J. Strauss, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, Winette T.A. van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, Javier Martín‐Broto, Antonio López–Pousa, Giovanni Grignani, Umberto Basso, Jean‐Yves Blay, Oscar Tendero, Robert Díaz Beveridge, Virginia Ferraresi, Iwona Ługowska, Domenico Franco Merlo, Valeria Fontana, Emanuela Marchesi, Davide María Donati, Elena Palassini, Emanuela Palmerini, Rita De Sanctis, Carlo Morosi, Silvia Stacchiotti, Sílvia Bagué, J.M. Coindre, Angelo Paolo Dei Tos, Piero Picci, Paolo Bruzzi, Paolo G. Casali